When: 200 SMA ($197.81) tested with reversal candle

Then: Secondary tranche entry at $200-205

When: 10Y yield below 4.50%

Then: Upgrade to Overweight posture

When: Close below $207 on volume >200M

Then: Reduce toward 40-50% of benchmark (honors Aug 26 trim-guard at actual trigger level)

HOLD on current tranche; maintain Overweight portfolio posture with stop at 207.50 and macro hedge in place; do not add capital at 219

• Trailing P/E of 27.7 faces contraction risk as Fed is hiking with Polymarket pricing 95% no-cut probability for 2026; "priced in is what people say right before the second leg down hits"
• Beta of 2.22 means a 5% market selloff on hawkish surprise would push NVDA down 10-11%
• MACD below signal line since early September with gap widened to minus 1.18 from peak of 4.16 is a "real technical warning"
• RSI oscillating 64 to 38 to 63 to 44 to 52 represents "a stock getting sold every time it tries to break out", not a structural bull pattern
• Accounts receivable up 127% against revenue up 106% signals customers taking longer to pay; inventory up 111% against revenue up 106% means production outpacing sales—potential write-down precursor if hyperscaler capex pauses
• Compressed ATR means next move will be violent in either direction; downside volatility expansion is "every bit as plausible as the upside" given hawkish Fed and sticky yields
• Sentiment at 7 out of 10 bullish with medium confidence represents peak consensus creating distribution risk; Reddit WSB positioning with short-dated YOLO calls shows leverage chasing momentum, not conviction
• Rubin doubling 2027 call is a 15-month catalyst with zero risk discount applied—pricing 2027 revenue at today's multiple is not "how a conservative book should be run"
• Retest of 50 SMA at 213.67 is "meaningfully higher" probability than aggressive analyst admits given beta of 2.22 and hawkish Fed
• "Anyone telling you to chase this name at 219 right now is selling you conviction in place of caution"

→ vs aggressive: Forward P/E of 14 and PEG of 0.45 are "trump cards" only if analyst consensus EPS of $15.61 is correct—but consensus has been wrong on NVDA before; trailing multiple of 27.7 has much more room to compress than value names when rates rise

→ vs aggressive: MACD divergence is not "nonsense"—it is below signal since early September with gap at minus 1.18 and declining from peak of 4.16; dismissing it shows "overconfidence that gets desks blown up"

→ vs aggressive: Two oversold RSI prints within six weeks frames weakness as strength; RSI 64→38→63→44→52 is not a "structural bull pattern"—it is a stock that cannot hold gains

→ vs aggressive: ATR compression argument presents only upside scenario; coiled springs release in either direction and downside volatility is "every bit as plausible" given hawkish Fed, sticky yields, and customer concentration risk

→ vs aggressive: Inventory and receivables growing faster than revenue is not a "strategic land grab"—it is a "remarkably convenient interpretation"; AR up 127% versus revenue 106% means slower customer payments; inventory up 111% versus revenue 106% means production outpacing sales

→ vs aggressive: "Broadest, deepest, most one-way bullish news flow" framing is precisely when smart money starts distributing; sentiment 7/10 with WSB YOLO calls on short-dated options is crowded positioning that "unwinds violently"

→ vs aggressive: "We may never see 213" is "the most dangerous thing" said—it is "FOMO dressed up as analysis"; 50 SMA at 213.67 reclaimed yesterday with beta 2.22 makes retest "meaningfully higher" probability

→ vs aggressive: Rubin doubling 2027 call is 15 months away with execution risk, custom ASIC competitive risk, customer concentration risk, and macro risk—pricing 2027 revenue at today's multiple gives zero discount for any of these risks

Hold core Overweight with 25-33% tactical add at ~$219 (stop $215-216), implement macro hedge overlay (SOXS or SPY put spreads), keep $207.50 hard stop on broader position and $231 breakout trigger for next tranche

• Forward P/E 14x with PEG of 0.45 indicates stock is cheap on fundamentals
• 50 SMA reclaimed at 213.67; two oversold RSI prints in six weeks shows stock sold hard on breakout attempts
• Beta 2.22 means NVDA amplifies macro moves both ways in a hiking Fed environment
• Institutional news flow (Rubin doubling, Salesforce, Verizon 6G, IonQ quantum, Nebius price raise) validates pricing power
• Forward EPS $15.61 reflects 106% YoY revenue growth and five quarters of operating leverage
• Sentiment at 7/10 with medium confidence—not extreme euphoria, constructive skepticism with positive tilt
• Working capital (AR and inventory build) uncertainty to be resolved by Q3 FY27 print in late October
• Key risk: Polymarket 95% no-cut number moved up 2.5 percentage points this week—macro still actively repricing
• Wait for $213 risks missing upside; entry at $219 with hedge and tight stop offers better risk-adjusted expected value

→ vs aggressive: Overreaching on 'macro priced in'—Polymarket moved 2.5pp this week, market still repricing rate path actively

→ vs aggressive: 'Never see $213' is FOMO dressed as analysis—retest probability closer to 60% given consolidation, $230-231 resistance, and macro overhang

→ vs aggressive: Contradiction: 'oversold prints mean strong hands' AND 'buyers in control' cannot coexist with 'we may never see $213'—the prints also support distribution thesis

→ vs conservative: 'Peak consensus bullishness' is premature—sentiment at 7/10 medium, not 9/10 high; retail YOLO flow is small relative to institutional flows

→ vs conservative: Cannot simultaneously dismiss strong recent execution AND use macro compression argument—they work against each other

→ vs conservative: 'Cost of missing 2 ATR' justifies no adds conflates process integrity with 'do nothing'—small tactical add with tight stop doesn't violate tranche framework